Celiac Wire

Pipeline

Treatments beyond the gluten-free diet

Several approaches have reached randomised trials. None has replaced the diet, and the field has a long history of promising results that did not hold.

Updated 3 min read 39 citations Evidence strength 3/5

Printed ingredient declaration on the back of a food package
Chenspec · CC BY-SA 4.0 · Wikimedia Commons

Why a drug is hard

Coeliac disease has an unusual property among autoimmune conditions: the trigger is known and removable. That sets a very high bar — any drug must be safer and more convenient than simply not eating gluten, in a population that is not acutely ill once treated. It also means the realistic target is not "eat bread again" but "be protected when the restaurant gets it wrong".

Transglutaminase 2 inhibition

Tissue transglutaminase modifies gluten peptides in a way that makes them far more immunogenic — it is the enzyme at the centre of the disease mechanism and the target of the antibody used to diagnose it. Blocking it is therefore mechanistically elegant. A randomised trial of a TG2 inhibitor reported attenuation of gluten-induced mucosal injury during challenge [5], which is the most encouraging single result the field has produced.

TG2 inhibition

Enzymatic degradation

Glutenases aim to break gluten down in the stomach before it reaches the small intestine. The engineering problem is severity: to protect against a normal wheat meal an enzyme must degrade grams of protein in a hostile acidic environment within a short window. Several candidates have shown activity against small quantities without demonstrating protection against realistic exposure. Work on probiotic preparations with in vivo gluten-degrading activity illustrates the approach.

Probiotics

A systematic review and meta-analysis of randomised controlled trials of probiotics for coeliac disease exists and does not support routine use. Microbiome differences in coeliac disease are real and reproducible, but modifying them has not translated into clinical benefit.

Other directions

  • Immune tolerance induction. Peptide-based approaches aiming to retrain the immune response, conceptually similar to allergen immunotherapy.
  • Tight junction modulation. Reducing intestinal permeability so fewer gluten peptides cross. Trials have been mixed.
  • Cytokine blockade. Aimed at refractory disease rather than at ordinary coeliac disease [7].
  • Vaccination. Long-discussed, repeatedly delayed, and not close.

What to expect

The plausible next step is an adjunct that reduces the consequences of accidental exposure for people who are already strict. That would be genuinely valuable — inadvertent exposure is common, as the contamination research shows — without being the freedom the coverage tends to promise.

Ingredient list text printed on a food wrapper
Chenspec · CC BY-SA 4.0 · Wikimedia Commons

Common questions

Will there be a pill that lets me eat bread?
Not on current evidence. The trials target protection against contamination, not resumption of a normal diet.
Should I take a gluten-digesting enzyme?
They have not been shown to protect against meal-sized gluten exposure, and relying on one is risky.
Are probiotics worth trying?
Meta-analysis of randomised trials does not support them for coeliac disease specifically.
How would I join a trial?
National coeliac societies and clinical trial registries list recruiting studies; your gastroenterologist can advise on eligibility.
The evidence behind this page A stacked bar showing the composition of the 39 publications cited on this page by study type. 183153meta-analysis (18)randomised trial (3)review (15)other (3)
39 publications, 1985–2026. That is a mix with both trials and syntheses in it, which is the position from which a claim about cause is reasonable. Source: this page’s own citation list, below.

References

Every citation below links to the original peer-reviewed record on PubMed or via DOI. Nothing here is a substitute for medical advice.

  1. European Society for the Study of Coeliac Disease (ESsCD) 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 2: Management, Follow-Up, and Complex Disease Courses Al-Toma A, Branchi F, Zingone F, et al. · United European gastroenterology journal · 2026 · Clinical guideline DOIPubMed 41831197Full text
  2. Prebiotic Supplementation in Celiac Disease: A Systematic Review of Clinical Efficacy, Safety, and Nutritional Outcomes Shahzil M, Irfan MZ, Kazmi SK, et al. · Journal of gastrointestinal and liver diseases : JGLD · 2026 · Systematic review DOIPubMed 42365652
  3. Physical Activity in Patients with Celiac Disease: A Systematic Review Zapata-Martínez I, Herrador-López M, Navas-López VM, et al. · Nutrients · 2026 · Systematic review DOIPubMed 42514469Full text
  4. Assessment of growth status and nutritional management of prematurely born infants after hospital discharge: A position paper of the ESPGHAN Nutrition Committee Haiden N, Luque V, Domellöf M, et al. · Journal of pediatric gastroenterology and nutrition · 2025 · Clinical guideline DOIPubMed 40341618
  5. European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach Al-Toma A, Zingone F, Branchi F, et al. · United European gastroenterology journal · 2025 · Clinical guideline DOIPubMed 40999951Full text
  6. Italian guidelines for the diagnosis and treatment of functional dyspepsia - joint consensus from the Italian societies of gastroenterology and endoscopy (SIGE), Neurogastroenterology and motility (SINGEM), hospital gastroenterologists and endoscopists (AIGO), digestive endoscopy (SIED) and general medicine (SIMG) Sarnelli G, Pesce M, Barbara G, et al. · Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2025 · Clinical guideline DOIPubMed 40628573
  7. Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023) Homan M, Jones NL, Bontems P, et al. · Journal of pediatric gastroenterology and nutrition · 2024 · Clinical guideline DOIPubMed 39148213
  8. Diet-microbiota associations in gastrointestinal research: a systematic review Duncanson K, Williams G, Hoedt EC, et al. · Gut microbes · 2024 · Systematic review DOIPubMed 38725230Full text
  9. Psychological, Psychiatric, and Organic Brain Manifestations of Celiac Disease Ciaccio EJ, Lee AR, Lebovits J, et al. · Digestive diseases (Basel, Switzerland) · 2024 · Systematic review DOIPubMed 38861947
  10. Single-Cell Meta-Analysis of Neutrophil Activation in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children Reveals Potential Shared Immunological Drivers Beltran JVB, Lin FP, Chang CL, et al. · Circulation · 2023 · Meta-analysis DOIPubMed 37905415
  11. Celiac disease and COVID-19 in adults: A systematic review Amirian P, Zarpoosh M, Moradi S, et al. · PloS one · 2023 · Systematic review DOIPubMed 37192180Full text
  12. ACG Clinical Guideline: Management of Irritable Bowel Syndrome Lacy BE, Pimentel M, Brenner DM, et al. · The American journal of gastroenterology · 2021 · Clinical guideline DOIPubMed 33315591
  13. The role of gluten-free diet in nonalcoholic fatty liver disease development Larussa T, Abenavoli L, Procopio AC, et al. · European review for medical and pharmacological sciences · 2021 · Systematic review DOIPubMed 34787864
  14. Gluten sensitivity and epilepsy: a systematic review Julian T, Hadjivassiliou M, Zis P · Journal of neurology · 2019 · Systematic review DOIPubMed 30167878Full text
  15. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders Al-Toma A, Volta U, Auricchio R, et al. · United European gastroenterology journal · 2019 · Clinical guideline DOIPubMed 31210940Full text
  16. ACG clinical guidelines: diagnosis and management of celiac disease Rubio-Tapia A, Hill ID, Kelly CP, et al. · The American journal of gastroenterology · 2013 · Clinical guideline DOIPubMed 23609613Full text
  17. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases Gastroenterology · 2003 · Clinical guideline DOIPubMed 12612916
  18. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology Scott EM, Gaywood I, Scott BB · Gut · 2000 · Clinical guideline DOIPubMed 10647595Full text
  19. Hepatic Steatosis and Diet in Adult Celiac Disease: A Cross-Sectional Study Peresztegi MZ, Szakács Z, Farkas N, et al. · Nutrients · 2025 · Randomised controlled trial DOIPubMed 41305627Full text
  20. Effect of Aspergillus niger prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet Stefanolo JP, Segura V, Grizzuti M, et al. · World journal of gastroenterology · 2024 · Randomised controlled trial DOIPubMed 38617446Full text
  21. A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease Schuppan D, Mäki M, Lundin KEA, et al. · The New England journal of medicine · 2021 · Randomised controlled trial DOIPubMed 34192430
  22. Chapter 4: Differential diagnosis of primary hyperparathyroidism Kamenický P, Houillier P, Vantyghem MC · Annales d'endocrinologie · 2025 · Review DOIPubMed 39818292
  23. Rotavirus Infections: Pathophysiology, Symptoms, and Vaccination Pawłuszkiewicz K, Ryglowski PJ, Idzik N, et al. · Pathogens (Basel, Switzerland) · 2025 · Review DOIPubMed 40430800Full text
  24. AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review DeLoughery TG, Jackson CS, Ko CW, et al. · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024 · Review DOIPubMed 38864796
  25. Advances in Nonresponsive and Refractory Celiac Disease Malamut G, Soderquist CR, Bhagat G, et al. · Gastroenterology · 2024 · Review DOIPubMed 38556189
  26. AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review Moshiree B, Drossman D, Shaukat A · Gastroenterology · 2023 · Review DOIPubMed 37452811
  27. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review Green PHR, Paski S, Ko CW, et al. · Gastroenterology · 2022 · Review DOIPubMed 36137844
  28. Celiac disease and bone Kondapalli AV, Walker MD · Archives of endocrinology and metabolism · 2022 · Review DOIPubMed 36382765Full text
  29. Epidemiology of Non-Hodgkin's Lymphoma Thandra KC, Barsouk A, Saginala K, et al. · Medical sciences (Basel, Switzerland) · 2021 · Review DOIPubMed 33573146Full text
  30. Small and Large Intestine (I): Malabsorption of Nutrients Montoro-Huguet MA, Belloc B, Domínguez-Cajal M · Nutrients · 2021 · Review DOIPubMed 33920345Full text
  31. Medical Care of Adults With Down Syndrome: A Clinical Guideline Tsou AY, Bulova P, Capone G, et al. · JAMA · 2020 · Review DOIPubMed 33079159
  32. Gluten-related disorders: Celiac disease, wheat allergy, and nonceliac gluten sensitivity Cabanillas B · Critical reviews in food science and nutrition · 2020 · Review DOIPubMed 31402697
  33. Osteoporosis and inflammation Lacativa PG, Farias ML · Arquivos brasileiros de endocrinologia e metabologia · 2010 · Review DOIPubMed 20485900
  34. Celiac disease Rodrigo L · World journal of gastroenterology · 2006 · Review DOIPubMed 17075969Full text
  35. [Adult celiac disease] Cellier C, Grosdidier E · La Revue du praticien · 2001 · Review PubMed 11458609
  36. Small intestinal lymphoma Cooper BT, Read AE · World journal of surgery · 1985 · Review DOIPubMed 3936285
  37. Reply Walker MD, Lebwohl B, Green PHR · Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2020 · Journal article DOIPubMed 31376492
  38. Tempters and Gluten-Free Diet Catassi C, Fasano A · Nutrients · 2016 · Journal article DOIPubMed 27918479Full text
  39. Not knowing Mantovani JF · Developmental medicine and child neurology · 2003 · Journal article PubMed 12578231